Agary Pharmaceutical
Agary Pharmaceutical Limited is a Lagos-based Nigerian company that imports, manufactures, and distributes pharmaceuticals, hospital consumables, medical devices, diagnostics, and personal care products to hospitals, pharmacies, laboratories, distributors, and consumers across Nigeria.
- Company typePrivate
- Founded1990
- HeadquartersAmuwo, Nigeria
- Headcount251–500
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Agary Pharmaceutical does
Agary Pharmaceutical Limited is a Nigerian pharmaceutical company that imports, manufactures, and distributes a broad portfolio of pharmaceutical products, hospital consumables, medical equipment, diagnostics, and personal care items. Founded circa 1990-1992 and headquartered in Lagos with regional depots in Kano and Onitsha, the company operates with 251-500 employees and serves hospitals, pharmacies, laboratories, distributors, and increasingly direct consumers across Nigeria. Its product mix combines locally manufactured and repackaged pharmaceuticals with imported specialty lines, including the German Doppelherz supplement range (30+ SKUs via exclusive Nigerian distribution of Queisser Pharma), Andon Health medical devices, and Accoson diagnostic instruments.
The business model is a hybrid of importation/wholesale distribution and light local manufacturing, monetizing across institutional procurement (hospital and pharmacy channels), third-party distributor networks, and a newly launched direct-to-consumer channel via the agarypharm.com/store e-commerce site supplemented by WhatsApp and phone ordering. Pricing spans low-cost personal care items (around ₦1,000) to premium diagnostic equipment (around ₦114,000), supporting a wide customer base. Exclusive distribution contracts with international principals (Queisser, Andon, Accoson) are the primary source of portfolio differentiation, and the Lagos-Kano-Onitsha depot footprint provides national logistics reach. There is no disclosed revenue, no disclosed external funding, and no evidence of AI/ML capability; growth is being pursued through channel expansion and product diversification rather than technology-led differentiation.
Agary Pharmaceutical firmographics
Firmographics- Name
- Agary Pharmaceutical
- Legal name
- Agary Pharmaceutical Limited
- Website
- https://agarypharm.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Agary Pharmaceutical Limited is a Lagos-based Nigerian company that imports, manufactures, and distributes pharmaceuticals, hospital consumables, medical devices, diagnostics, and personal care products to hospitals, pharmacies, laboratories, distributors, and consumers across Nigeria.
- Ownership category
- akta.pro rank
Agary Pharmaceutical industry classification
Industry- Product category
- Pharmaceutical Distribution & Manufacturing
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Agary Pharmaceutical is headquartered
LocationHeadquarters
- HQ city
- Amuwo
- HQ country
- Nigeria
- HQ region
- Africa
Offices3 records
Markets served
Agary Pharmaceutical business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Sale of drugs, medical equipment, hospital consumables, diagnostics, wellbeing products, and personal care items through direct sales and e-commerce platform.
- International Brand Distribution: Sole distribution of international healthcare brands including Queisser Pharma (Doppelherz), Andon, and Accoson in Nigeria. Revenue generated from distributing and reselling internationally manufactured pharmaceutical and medical products.
- Raw Materials Distribution: Distribution of pharmaceutical raw materials to manufacturers and other businesses in the healthcare industry.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Doppelherz supplement products |
| Unit Pricing | Pay-as-you-go | Diagnostics and medical equipment products |
| Unit Pricing | Pay-as-you-go | Personal care and specialty products |
| Unit Pricing | Pay-as-you-go | Specialized supplements |
| Unit Pricing | Pay-as-you-go | Premium collagen and beauty products |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Agary Pharmaceutical product offering
Product offeringCore offering
Agary Pharmaceutical Limited manufactures, distributes, and serves as the sole Nigerian representative for select international healthcare brands. Its portfolio spans pharmaceuticals (prescription and OTC), pharmaceutical raw materials (APIs), wellness and nutritional supplements under the Doppelherz brand from Queisser Pharma (Germany), hospital consumables, medical equipment (sphygmomanometers, infrared thermometers), diagnostics (blood glucose monitoring systems and test strips), and personal care products (adult diapers, pregnancy test strips).
Product overview
Agary Pharmaceutical Limited is a Nigerian pharmaceutical company serving as a manufacturer, distributor, and sole representative of international healthcare brands. The company operates a diversified portfolio across multiple product categories: (1) Doppelherz branded wellbeing supplements including multivitamins, cardiovascular health, bone health, eye health, immune support, reproductive health, children's health, and beauty/collagen products; (2) Stozzon Chlorophyll Dragees for oral and body odor; (3) Diagnostics including Agary branded blood glucose monitoring systems and test strips, CK-T1501 non-contact infrared thermometers, and pregnancy test strips; (4) Medical Equipment including Accoson sphygmomanometers and Andon automatic blood pressure monitors; and (5) Personal Care including adult diapers. The Doppelherz product line, distributed in partnership with Queisser Pharma Germany, forms the core wellbeing offerings with approximately 30+ distinct supplement products addressing various health needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Doppelherz Wellness Supplements (Queisser Pharma, Germany)
- Stozzon Chlorophyll Dragees
- Accoson Sphygmomanometers
- Andon Automatic Blood Pressure Monitor
- Agary Blood Glucose Monitoring System
Quantifiable outcome
- Over 30 years of unwavering dedication to delivering quality healthcare products
- +1 more outcomes
Companies that use Agary Pharmaceutical
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles6 records
Agary Pharmaceutical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Agary Pharmaceutical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Queisser Pharma (Germany)coreQueisser Pharma is a globally respected name in the pharmaceutical and healthcare industry known for premium products supporting overall health and well-being. Through this partnership, Agary brings trusted Doppelherz brand products to the Nigerian market, including multivitamins, dietary supplements, and wellness products. Agary serves as the sole/d sole distributor for Queisser Pharma products in Nigeria.
- AndoncoreAndon is a leading manufacturer of advanced medical diagnostic devices. Their partnership enhances Agary's capacity to deliver state-of-the-art solutions for health monitoring including automatic blood pressure monitors. Their innovative technology empowers individuals to take control of their health with precision and convenience.
- AccosoncoreAccoson is a globally recognized leader in the production of sphygmomanometers and medical equipment. Their partnership strengthens Agary's position as a trusted supplier of hospital consumables and diagnostic tools. Their precision manufacturing aligns with Agary's goal of advancing healthcare standards in Nigeria.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Agary Pharmaceutical competitors and assessment
Company assessmentRegional players
- HealthPlus Nigeria: Major Nigerian pharmacy chain selling pharmacy, wellness, and personal care products. Comparable as a downstream retail customer for Agary's distribution portfolio within Nigeria.
- Medplus Pharmacy: Large Nigerian pharmacy retail chain selling pharma, OTC, and personal care products. Comparable as a downstream counterpart in the same Nigerian distribution pipeline; Agary supplies while Medplus sells.
Direct peers
- May & Baker Nigeria: Long-established Nigerian pharmaceutical manufacturer and distributor across prescription, OTC, and consumer health. Comparable on broad pharma distribution to hospitals, pharmacies, and retailers in Nigeria.
- Emzor Pharmaceutical Industries: Largest indigenous Nigerian pharmaceutical manufacturer and distributor. Directly comparable on broad-line pharma distribution, hospital supplies, and consumer health products serving Nigeria's hospital, pharmacy, and OTC channels.
- Neimeth International Pharmaceuticals: Listed Nigerian pharma company manufacturing and marketing prescription and consumer health products. Comparable on local manufacturing plus distribution to hospitals, pharmacies, and consumers in Nigeria.
- Fidson Healthcare: Listed Nigerian pharma manufacturer and marketer with a wide generics and consumer health portfolio. Comparable on full-stack manufacturing + nationwide distribution of drugs, supplements, and hospital consumables in Nigeria.
Broad incumbents
- Sanofi Nigeria: Multinational pharma's Nigerian operation covering prescription, vaccines, and consumer health. Comparable as a broad pharma presence in Nigeria's hospital and pharmacy channels.
- Pfizer Nigeria: Multinational pharmaceutical company with an established Nigerian subsidiary. Comparable as a broad incumbent in the same hospital/pharmacy channel, though Pfizer is primarily a prescription-drug manufacturer rather than a consumer-health distributor.
- GlaxoSmithKline Consumer Nigeria: Multinational OTC and consumer health player in Nigeria. Comparable as a broad incumbent distributing health and personal care SKUs through Nigerian retail and pharmacy channels.
- GSK Consumer Healthcare Nigeria: Subsidiary of GSK selling OTC and consumer health brands in Nigeria. Comparable as a multinational pharma presence in Nigerian pharmacy and hospital channels, though with a broader global portfolio and broader geographic footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Agary Pharmaceutical social profiles
Digital presenceAgary Pharmaceutical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Agary Pharmaceutical leadership team
Management profileNumber of profiles
Profiles1 record
Agary Pharmaceutical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Agary Pharmaceutical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Agary Pharmaceutical
What does Agary Pharmaceutical do?
Agary Pharmaceutical Limited manufactures, distributes, and serves as the sole Nigerian representative for select international healthcare brands. Its portfolio spans pharmaceuticals (prescription and OTC), pharmaceutical raw materials (APIs), wellness and nutritional supplements under the Doppelherz brand from Queisser Pharma (Germany), hospital consumables, medical equipment (sphygmomanometers, infrared thermometers), diagnostics (blood glucose monitoring systems and test strips), and personal care products (adult diapers, pregnancy test strips).
Is Agary Pharmaceutical a public or private company?
Agary Pharmaceutical is a private company. It is classified as unknown and is currently operating.
When was Agary Pharmaceutical founded?
Agary Pharmaceutical was founded in 1990. It employs 251 to 500 people.
Where is Agary Pharmaceutical based?
Agary Pharmaceutical is headquartered in Amuwo, Nigeria, in the Africa region.
How does Agary Pharmaceutical make money?
Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are international Brand Distribution and raw Materials Distribution.
Who are Agary Pharmaceutical's main competitors?
Regional players on record are HealthPlus Nigeria and Medplus Pharmacy. Direct peers are May & Baker Nigeria, Emzor Pharmaceutical Industries, Neimeth International Pharmaceuticals and Fidson Healthcare. Broad incumbents are Sanofi Nigeria, Pfizer Nigeria, GlaxoSmithKline Consumer Nigeria and GSK Consumer Healthcare Nigeria.
Does Agary Pharmaceutical have an API?
No public API is recorded for Agary Pharmaceutical.
What industry is Agary Pharmaceutical in?
Agary Pharmaceutical's product category is Pharmaceutical Distribution & Manufacturing. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 424210 and its SIC code is 5122.